-
Valemetostat: An Assay-First Lymphoma Framework
2026-08-24
Valemetostat (DS-3201) is a potent EZH2-focused epigenetic cancer therapy with a distinctive assay and translational profile. This guide connects mutation-aware pharmacology, orthogonal readouts, and evidence boundaries for more rigorous lymphoma research.
-
QSHXO in MASLD: Autophagy and Ferroptosis
2026-08-24
Liu et al. investigated how Qushi Huoxue ointment (QSHXO) protects against metabolic associated steatotic liver disease in mice, identifying coordinated autophagy activation and ferroptosis suppression as a central mechanistic model. The work integrates histology, biochemical testing, LC-MS/MS, network pharmacology, molecular assays, and ultrastructural analysis to connect reduced lipid injury with Nrf2-linked antioxidant defense.
-
HRD1-SEL1L, ER Stress, and Stress Granule Homeostasis
2026-08-23
The 2024 iScience study identifies the HRD1-SEL1L ubiquitin ligase complex as a selective regulator of heat shock-induced stress granule homeostasis. Its experiments connect the ubiquitin-proteasome system and p97 to the BiP-PERK-eIF2α branch of the unfolded protein response, showing that distinct ER-stress pathways can have different effects on stress granule dynamics.
-
Lactate as a Metabolic Signal in Tumor Immunity
2026-08-22
Lactate is more than a glycolytic byproduct: it connects redox balance, hypoxia, mitochondrial metabolism, and immune regulation. This guide explains how L-lactate can support mechanistic assays, with emphasis on the NAT1–ENO1–lactate axis in colorectal cancer.
-
Silymarin Workflows for Redox and Cancer Research
2026-08-22
Silymarin is a chemically complex milk thistle extract that connects oxidative-stress, hepatocellular carcinoma, metabolic, and antiviral assay design. This practical guide shows how to prepare, dose, validate, and troubleshoot the compound without confusing a flavonolignan mixture with a single purified molecule.
-
ROS-Responsive LNPs for Mutant RAS mRNA Delivery
2026-08-21
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a tumor-preferential mRNA delivery material. Its delivery of DUF5 mRNA depleted mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models, while also highlighting the importance of lipid pKa and ROS-triggered degradation.
-
Phosphotungstic Acid Negative Stain Solution Guide
2026-08-20
Build a practical negative stain electron microscopy workflow for viruses, macromolecules, bacteria, and organelles using a ready-to-use 2% reagent. Learn how to convert glycan-focused antiviral findings into controlled morphology assays without mistaking particle visualization for proof of molecular binding or antiviral efficacy.
-
From Reporter mRNA to Translational Delivery
2026-08-20
A mechanistic and strategic guide to using Cap1-capped, 5-moUTP-modified Firefly Luciferase mRNA as a translational reporter while interpreting delivery, stability, innate immune, and nebulization variables.
-
Otilonium Bromide: Applied Research Workflows
2026-08-19
Build reproducible antimuscarinic assays with Otilonium Bromide by combining controlled exposure, matched vehicle controls, and orthogonal functional readouts. This workflow-oriented guide shows how to use the compound in smooth muscle, neuronal, and gastrointestinal motility studies while separating practical assay guidance from evidence generated in computational inhibitor screening.
-
ATP Solution (100 mM) in Translational Assays
2026-08-19
Discover how ATP Solution and Adenosine-5'-triphosphate quality influence kinase, transcription, ligation, and phosphorylation workflows. This article connects reagent control to the assay decisions underlying localized p21 mRNA-LNP research in bladder cancer.
-
Resibufogenin Blocks NLRP3 in Atherosclerosis
2026-08-18
The reference study identifies resibufogenin as a preclinical inhibitor of NLRP3 inflammasome assembly and links this activity to reduced plaque inflammation, lipid accumulation, fibrosis, and macrophage foam-cell formation in ApoE−/− mice. Its combination of animal, cellular, docking, and surface plasmon resonance experiments provides a mechanistic framework for evaluating NLRP3-directed interventions in atherosclerosis.
-
EdU Cell Proliferation Kit for RA Research
2026-08-18
Apply a non-radioactive EdU workflow to quantify DNA synthesis in rheumatoid arthritis fibroblast-like synoviocytes and drug-response studies. This TMB-based format combines click chemistry with microplate detection, making it practical for scalable cell proliferation measurement and mechanistic validation.
-
Exercise Limits Precede Muscle Dysfunction in PH
2026-08-17
This study separates cardiopulmonary and skeletal-muscle contributions to exercise intolerance in experimental pulmonary hypertension. Across rat strains and disease severities, reduced VO2 max appeared with right-ventricular dysfunction before major intrinsic changes in muscle structure, mitochondrial respiration, force, or fatigue resistance.
-
WIP1, p38 MAPK, and Pyroptosis in Septic AKI
2026-08-17
The reference study identifies WIP1/PPM1D as an inhibitory regulator of p38 MAPK-driven pyroptosis in sepsis-associated acute kidney injury. By combining single-cell transcriptomics with mouse and HK2-cell experiments, it connects increased tubular WIP1 activity with protection from inflammatory cell death and provides a mechanistic framework for studying renal injury.
-
BPN-19186 in Osteoclastogenesis Research
2026-08-16
BPN-19186 offers a high-purity, fluorinated small-molecule starting point for probing enzyme inhibition studies, redox signaling, and osteoclast differentiation. This workflow connects compound handling with metabolite, Nrf2-ARE, and liver–bone-axis readouts while clearly separating established evidence from exploratory applications.